In the past, we have shown, through a targeted hormonal investigation, the differential regulation of GLP-1, activins/follistatins, insulin, and insulin growth factors across a wide range of MASLD pathologies [35]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.